Volume 8, Issue 2 (Spring 2020)                   Iran J Health Sci 2020, 8(2): 23-31 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Seyedalinaghi S, Farhoudi B, Harandi H, Mahalleh M, Dadras O, Alipour A et al . A study of barriers to adherence of antiretroviral treatment in prisoners living with HIV in Tehran, Iran. Iran J Health Sci. 2020; 8 (2) :23-31
URL: http://jhs.mazums.ac.ir/article-1-705-en.html
Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran , b_farhoudi@yahoo.com
Abstract:   (511 Views)
Background: People with chronic illnesses, such as HIV infection, face many barriers in the way of adherence to the treatment. In this study, the researchers attempted to investigate the barriers and facilitators of adherence to antiretroviral therapy (ART) among patients with HIV.
Methods: Focus group discussion (FGD) was conducted with the primary objectives of investigating the barriers to ART adherence. Nine participants with HIV infection were recruited through a purposive sampling method at Great Tehran Prison.
Results: In terms of the influencing factors of non-adherence; the drug side effects, especially with Efavirenz, Methadone and opioids effects resolution due to interaction with antiretroviral drugs, forgetfulness, fear of hangover due to the missed or delayed Methadone use, inappropriate nutrition and lack of access to food supplements and poverty were noted by majority of participants. In addition, there were some less, but still important factors of non-adherence among the patients, which were mentioned in the manuscript of the article.
Conclusion: The medications side effects, inappropriate methadone prescription, stigma, lack of family support, and unfavorable prison conditions were found to be the potential barriers of adherence to HIV medication, whilst a strong and realistic patient-physician relationship, psychosocial and family support, and knowledge regarding the level of CD4 were amongst the possible facilitators for adherence to HIV medication in HIV-positive prisoners.
 
 
Full-Text [PDF 425 kb]   (139 Downloads)    
Type of Study: Original Article | Subject: Health

References
1. Moradi F, Nabaei B, and Yeganeh B. The epidemiology of AIDS in Iran from beginning until now. Tehran University Medical Journal. 2000; 58(4): 79-88.
2. Golrokhi R., et al. HIV Prevalence and Correlations in Prisons in Different Regions of the World: A Review Article. The open AIDS journal. 2018; 12: 81-92. [DOI:10.2174/1874613601812010081] [PMID] [PMCID]
3. UNAIDS. Fact sheet - global AIDS update 2019. Available from: https://www.unaids. org/en/resources/fact-sheet.
4. Seyed Alinaghi S.A., et al. Adherence to Antiretroviral Therapy and Tuberculosis Treatment in a Prison of Tehran, Iran. Infectious Disorders - Drug Targets. 2016; 16(3): 199-203. [DOI:10.2174/1871526516666160616111308] [PMID]
5. Khan M.D., et al. Prevalence and associated risk factors of HIV in prisons in Balochistan, Pakistan: a cross-sectional study. F1000Research. 2018.; 7: 1821. [DOI:10.12688/f1000research.16994.1] [PMID] [PMCID]
6. Farhoudi B, et al.,Barriers to Adherence to Antiretroviral Treatment Among Inmates of a Prison in Tehran, Iran: A Qualitative Study. Archives of Clinical Infectious Diseases. 2018;13(2):e57911. [DOI:10.5812/archcid.57911]
7. Farhoudi B, et al.,Revision and Implementation of "Clinical Guideline for Tuberculosis and HIV in Prisons", Great Tehran Prison, Iran. Infectious disorders drug targets. 2018;18(1): 72-80. [DOI:10.2174/1871526517666170518093529] [PMID]
8. SeyedAlinaghi S., et al. Evaluation of Stigma Index Among People Living With HIV/AIDS (PLWHA) in Six Cities in Iran. Thrita. 2013; 2(4):69-75. [DOI:10.5812/thrita.11801]
9. Rintamaki L.S., et al. Social stigma concerns and HIV medication adherence. AIDS Patient Care and STDs. 2006; 20(5): 359-68. [DOI:10.1089/apc.2006.20.359] [PMID]
10. Emamzadeh-Fard S., et al. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review. Infectious Disorders - Drug Targets. 2012;12(5): 346-56. [DOI:10.2174/187152612804142251] [PMID]
11. Shalihu N., et al. Namibian prisoners describe barriers to HIV antiretroviral therapy adherence. AIDS Care. 2014; 26(8):968-75. [DOI:10.1080/09540121.2014.880398] [PMID]
12. Wasti S.P., et al. Factors influencing adherence to antiretroviral treatment in Nepal: a mixed-methods study. PLoS One. 2012;7(5): e35547. [DOI:10.1371/journal.pone.0035547] [PMID] [PMCID]
13. Biadgilign S., et al. Barriers and facilitators to antiretroviral medication adherence among HIV-infected paediatric patients in Ethiopia: A qualitative study. SAHARA-J: Journal of Social Aspects of HIV/AIDS. 2009; 6(4): 148-54. [DOI:10.1080/17290376.2009.9724943] [PMID]
14. Kagee, A. and Delport T. Barriers to adherence to antiretroviral treatment: the perspectives of patient advocates. Journal of Health Psychology. 2010;15(7): 1001-11. [DOI:10.1177/1359105310378180] [PMID]
15. Mehraeen E., et al. Mobile-Based Applications and Functionalities for Self-Management of People Living with HIV. Studies in health technology and informatics. 2018;248: 172-179.
16. Wanyama J., et al. Belief in divine healing can be a barrier to antiretroviral therapy adherence in Uganda. Aids. 2007; 21(11):1486-7. [DOI:10.1097/QAD.0b013e32823ecf7f] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | Iranian Journal of Health Sciences

Designed & Developed by : Yektaweb